NCT04404244View on ClinicalTrials.gov

Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic

CompletedOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

November 1, 2023

Study Completion Date

January 1, 2024

Conditions

Coronavirus COVID-19

Trial Locations (1)

11566

Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo

All Listed Sponsors

lead

Fatma Soliman Elsayed Ebeid, MD

OTHER

NCT04404244 - Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic | Biotech Hunter | Biotech Hunter